Dr. Rodney JY Ho is a distinguished professor of pharmaceutics (SOP), adjunct professor of bioengineering (SOM) and is an inaugural presidential entrepreneurial fellow of the University of Washington. He is also a member of Fred Hutchinson Cancer Research Center. His research encompasses basic and translational sciences for improving the therapeutic efficacy and safety of viral and cancer drugs, diagnostic agents and vaccines. Ongoing programs aim to understand the interplay between drug target distribution and disease development in cancer, AIDS, and neurological disorders. Understanding of these interactions enable application of his discovery into novel device and nanomedicines selective for drug targets within cells and tissues in the body that could lead to a cure for AIDS. In addition to being an advocate of the Systems Approach to Drug Delivery and Targeting, he is an expert on protein therapeutics, lipid-drug and -protein interactions, liposomes, nanoparticles, pharmacokinetics, and the interplay between tissue targets and drug penetration As an editor of the Journal of Pharmaceutical Sciences, he has developed the Drug Delivery Clinical Trials and the PhRMA Pharmacokinetics Prediction Databases. He co-authored the book entitled, “Biotechnology and Biopharmaceuticals” (2nd edition; Wiley and Sons). He is also a scientific and board advisor to many organizations, including the NIH He received top honors including the Paul Dawson Biotechnology life-time achievement award, and the AAPS Biotechnology Research achievement, one of the highest AAPS’s recognition. He is an elected fellow of the American Association for the Advancement of Sciences and the American Association of Pharmaceutical Scientists (AAPS).
Conflict of Interest: None disclosed.